These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34748164)

  • 1. Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study.
    Clarke CS; Duffy L; Lewis G; Freemantle N; Gilbody S; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Marston L; Hunter RM
    Appl Health Econ Health Policy; 2022 Mar; 20(2):269-282. PubMed ID: 34748164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial.
    Duffy L; Bacon F; Clarke CS; Donkor Y; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Lewis G; Mangin D; Marston L; Moore M; Nazareth I; Wiles N; Lewis G
    Trials; 2019 Jun; 20(1):319. PubMed ID: 31159856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
    Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
    Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
    Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
    Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
    Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
    J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and long-term cost-effectiveness of a pedometer-based exercise intervention in primary care: a within-trial analysis and beyond-trial modelling.
    Anokye N; Fox-Rushby J; Sanghera S; Cook DG; Limb E; Furness C; Kerry SM; Victor CR; Iliffe S; Ussher M; Whincup PH; Ekelund U; deWilde S; Harris T
    BMJ Open; 2018 Oct; 8(10):e021978. PubMed ID: 30337309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
    Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
    Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT.
    McMillan A; Bratton DJ; Faria R; Laskawiec-Szkonter M; Griffin S; Davies RJ; Nunn AJ; Stradling JR; Riha RL; Morrell MJ
    Health Technol Assess; 2015 Jun; 19(40):1-188. PubMed ID: 26063688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.
    Salisbury C; Foster NE; Hopper C; Bishop A; Hollinghurst S; Coast J; Kaur S; Pearson J; Franchini A; Hall J; Grove S; Calnan M; Busby J; Montgomery AA
    Health Technol Assess; 2013 Jan; 17(2):1-157, v-vi. PubMed ID: 23356839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
    Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentred randomised controlled trial of a primary care-based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial.
    Lamb SE; Lall R; Hansen Z; Castelnuovo E; Withers EJ; Nichols V; Griffiths F; Potter R; Szczepura A; Underwood M;
    Health Technol Assess; 2010 Aug; 14(41):1-253, iii-iv. PubMed ID: 20807469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis.
    Clarke CS; Melnychuk M; Ramsay AIG; Vindrola-Padros C; Levermore C; Barod R; Bex A; Hines J; Mughal MM; Pritchard-Jones K; Tran M; Shackley DC; Morris S; Fulop NJ; Hunter RM
    Appl Health Econ Health Policy; 2022 Nov; 20(6):905-917. PubMed ID: 35869355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance or Discontinuation of Antidepressants in Primary Care.
    Lewis G; Marston L; Duffy L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; Mangin D; King M; Lanham P; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Clarke CS; Hunt A; Pervin J; Lewis G
    N Engl J Med; 2021 Sep; 385(14):1257-1267. PubMed ID: 34587384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.